Gastric antral vascular ectasia pathophysiology

Jump to navigation Jump to search

Gastric antral vascular ectasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Gastric antral vascular ectasia from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Endoscopy

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gastric antral vascular ectasia pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gastric antral vascular ectasia pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gastric antral vascular ectasia pathophysiology

CDC on Gastric antral vascular ectasia pathophysiology

Gastric antral vascular ectasia pathophysiology in the news

Blogs on Gastric antral vascular ectasia pathophysiology

Directions to Hospitals Treating Gastric antral vascular ectasia

Risk calculators and risk factors for Gastric antral vascular ectasia pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

GAVE is characterized by dilated capillaries in the lamina propria with fibrin thrombi.

Gross Pathology

Endoscopic image of gastric antral vascular ectasia


Microscopic Pathology

Micrograph showing gastric antral vascular ectasia. A large spherical, eosinophilic (i.e. pink) fibrin thrombus is seen off-center right. Stomach biopsy. H&E stain.


Asociated Conditions

GAVE is associated with a number of conditions, including

References

Template:WH Template:WS